What is the threshold for a clinically relevant effect? the case of major depressive disorders

Depression and Anxiety

Volumn 31, Issue 5, 2014, Pages 374-378

  Cuijpers, Pim ^a,b,c   Turner, Erick H ^d,e   Koole, Sander L ^a,b   Van Dijke, Annemiek ^f   Smit, Filip ^a,b,g  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEUPHANA UNIVERSITY OF LÜNEBURG   (Germany)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f Delta Psychiatrisch Centrum   (Netherlands)

^g NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

Author keywords

clinical relevance; depression; effect size; minimal important difference

Indexed keywords

EFFECT SIZE; HEALTH STATUS; HUMAN; MAJOR DEPRESSION; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; DEPRESSIVE DISORDER, MAJOR; MULTIMODALITY CANCER THERAPY; PSYCHOLOGY; PSYCHOMETRY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ANTIDEPRESSANT AGENT;

ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; PSYCHOTHERAPY;

EID: 84899478856     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22249     Document Type: Review

References (21)

1. National Institute for Clinical Excellence. Depression: Management of Depression in Primary and Secondary Care. Clinical Practice Guideline No 23. London: National Institute for Clinical Excellence; 2004.
2. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT,. Initial severity and antidepressant benefits: A meta-analysis of data submiteed to the food and drug administration. PLoS Med 2008; 5: 250-268.
3. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA 2010; 303: 47-53.
4. National Institute for Clinical Excellence. Depression: The Treatment and Management of Depression in Adults. Partial Update of Clinical Practice Guideline No 23. London: National Institute for Clinical Excellence; 2009.
5. Cohen J,. The earth is round (p <.05). Am Psychol 1994; 49: 997-1003
6. Cohen J,. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
7. Lipsey MW, Wilson DB,. The efficacy of psychological, educational, and behavioral treatment confirmation from meta-analysis. Am Psychol 1993; 48: 1181-1209.
8. Bauer S, Lambert MJ, Nielsen SL,. Clinical significance methods: A comparison of statistical techniques. J Pers Assess 2004; 82: 60-70. (Pubitemid 38134001)
9. Jacobsen N, Truax P,. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991; 59: 12-19.
10. Stiggelbout AM, Van der Weijden T, De Wit MPT, et al. Shared decision making: really putting patients at the centre of healthcare. BMJ 2012; 344: e256 doi: 10.1136/bmj.e256.
11. Jaeschke R, Singer J, Guyatt GH,. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-415. (Pubitemid 20025670)
12. Walters SJ, Brazier JE,. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005; 14: 1523-1532. (Pubitemid 40848233)
13. Ware JE Jr., Snow KK, Kosinski M, Gandek B,. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Centre; 1993.
14. Sanderson K, Andrews G, Corry J, Lapsley H,. Using the effect size to model change in preference values from descriptive health status. Qual Life Res 2004; 13: 1255-1264. (Pubitemid 39149609)
15. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R,. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008; 358: 252-260.
16. Cuijpers P, Turner EH, Mohr DC, et al. Comparison of psychotherapies for adult depression to pill placebo control groups: A meta-analysis. Psychol Med 2013 [Epub ahead of print].
17. Cuijpers P, van Straten A, Warmerdam L, Andersson G,. Psychological treatment of depression: A meta-analytic database of randomized studies. BMC psychiatry 2008; 8 (1): 36.
18. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis. Ann Intern Med 2011; 155: 772-785.
19. Cuijpers P, van Straten A, Andersson G, van Oppen P,. Psychotherapy for depression in adults: A meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008; 76: 909-922.
20. Barth J, Munder T, Gerger H, et al. Comparative efficacy of seven psychotherapeutic interventions for depressed patients: A network meta-analysis. Plos Med 2013; 10: e1001454.
21. Kraemer HC, Kupfer DJ,. Size of treatment effects and their importance to clinical research and practice. Biol psychiatry 2006; 59: 990-996. (Pubitemid 43849650)